Cargando…

Cost-effectiveness of universal HIV testing and treatment: where next?

Detalles Bibliográficos
Autores principales:	Nachega, Jean B, Borre, Ethan D, Dowdy, David W, Chanda-Kapata, Pascalina, Cleary, Susan, Geng, Elvin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295732/ https://www.ncbi.nlm.nih.gov/pubmed/33721567 http://dx.doi.org/10.1016/S2214-109X(21)00089-9

Ejemplares similares

Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa
por: Nachega, Jean B., et al.
Publicado: (2021)

The prevalence and socio-economic determinants of HIV among teenagers aged 15–18 years who were participating in a mobile testing population based survey in 2013–2014 in Zambia
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016)

The prevalence of HIV among adults with pulmonary TB at a population level in Zambia
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2017)

COVID-19 and malaria: A symptom screening challenge for malaria endemic countries
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2020)

The quest for a framework for sustainable and institutionalised priority-setting for health research in a low-resource setting: the case of Zambia
por: Kapiriri, Lydia, et al.
Publicado: (2018)

The adult prevalence of HIV in Zambia: results from a population based mobile testing survey conducted in 2013–2014
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016)

Developing a national health research system: participatory approaches to legislative, institutional and networking dimensions in Zambia
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2012)

Asserting public health interest in acting on commercial determinants of health in sub-Saharan Africa: insights from a discourse analysis
por: Loewenson, Rene, et al.
Publicado: (2022)

Evaluating health research priority-setting in low-income countries: a case study of health research priority-setting in Zambia
por: Kapiriri, Lydia, et al.
Publicado: (2018)

The where, when, and how of community-based versus clinic-based ART delivery in South Africa and Uganda
por: Nachega, Jean B, et al.
Publicado: (2020)

Genomic research in Zambia: confronting the ethics, policy and regulatory frontiers in the 21st Century
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2015)

Health research priority setting in Zambia: a stock taking of approaches conducted from 1998 to 2015
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016)

Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa – A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic()
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2022)

Tuberculosis among older adults in Zambia: burden and characteristics among a neglected group
por: Coffman, Jenna, et al.
Publicado: (2017)

How “Subclinical” is Subclinical Tuberculosis? An Analysis of National Prevalence Survey Data from Zambia( )
por: Stuck, Logan, et al.
Publicado: (2022)

Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2016)

Non-tuberculous mycobacteria (NTM) in Zambia: prevalence, clinical, radiological and microbiological characteristics
por: Chanda-Kapata, Pascalina, et al.
Publicado: (2015)

Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia
por: Hamainza, Busiku, et al.
Publicado: (2014)

Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2009)

A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia
por: Wang, Paul C., et al.
Publicado: (2015)

Impact assessment of malaria vector control using routine surveillance data in Zambia: implications for monitoring and evaluation
por: Chanda, Emmanuel, et al.
Publicado: (2012)

Where Next?
Publicado: (1897)

An audit of licenced Zambian diagnostic imaging equipment and personnel
por: Mbewe, Chitani, et al.
Publicado: (2020)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2007)

Wash-resistance of pirimiphos-methyl insecticide treatments of window screens and eave baffles for killing indoor-feeding malaria vector mosquitoes: an experimental hut trial, South East of Zambia
por: Chinula, Dingani, et al.
Publicado: (2018)

In Silico: Where Next?
por: Fairhall, Adrienne L.
Publicado: (2021)

Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management
por: Chanda, Pascalina, et al.
Publicado: (2011)

Malaria Vaccines: Where Next?
por: Holder, Anthony A.
Publicado: (2009)

Where Next for Genetics and Genomics?
por: Tyler-Smith, Chris, et al.
Publicado: (2015)

Where Next for Microbiome Research?
por: Waldor, Matthew K., et al.
Publicado: (2015)

Where is genomics going next?
por: Cheifet, Barbara
Publicado: (2019)

Nutritional Psychiatry: Where to Next?
por: Jacka, Felice N.
Publicado: (2017)

Cancer Immunotherapy: Where Next?
por: Bodmer, Walter, et al.
Publicado: (2023)

Universal Access to HIV Treatment versus Universal ‘Test and Treat’: Transmission, Drug Resistance & Treatment Costs
por: Wagner, Bradley G., et al.
Publicado: (2012)

Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers
por: Chanda, Pascalina, et al.
Publicado: (2011)

Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane(®)) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2006)

Advances in digital CBT: where are we now, and where next?
por: Thew, Graham R., et al.
Publicado: (2022)

Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs
por: Nachega, Jean B, et al.
Publicado: (2011)

NICE verdict on Temozolomide: where next?
por: Brada, M
Publicado: (2002)

Where next with therapy in advanced neuroblastoma?
por: Pinkerton, C. R.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_n3ehdi9lk8rbg4odj9i27s1gof